Accuray Prepares for Q1 Fiscal 2025 Financial Results
Accuray Incorporated (NASDAQ: ARAY) is ready to unveil its first quarter financial outcomes for fiscal year 2025, which culminated on September 30, 2024. This announcement will be made publicly during a live conference call scheduled for November 6, 2024, at 1:30 p.m. PT, or 4:30 p.m. ET, featuring insights and analyses from the company's management team.
Details of the Conference Call
Individuals wishing to join the conference call may do so by dialing in at (833) 316-0563 for attendees within the USA or (412) 317-5747 for international participants. Furthermore, a playback of this conference call will be accessible approximately one hour post event and will remain available for a week. The replay can be accessed by calling 1-877-344-7529 within the USA or 1-412-317-0088 internationally, using conference ID: 2342044.
Accessing the Webcast
For those who prefer a digital experience, Accuray will host a live webcast of the conference call available on the Investor Relations section of their website. The accessible links will ensure easy entry for stakeholders and other interested parties. Notably, the replay will be on the same platform until the company reveals its financial expectations for the second quarter of fiscal 2025.
About Accuray Incorporated
Accuray Incorporated (NASDAQ: ARAY) has been on a mission to revolutionize radiation therapy, harnessing innovative technology to enhance patient outcomes. Their commitment transcends standard treatment approaches, enabling practitioners to tackle complex medical situations while simplifying treatment for those with less complicated cases. Accuray's ongoing dedication towards innovation in oncology and neuro-radiosurgery places them at the forefront of delivering effective and timely solutions.
Company’s Vision and Commitment
At the heart of Accuray's mission lies the aspiration to make a significant impact on patient lives through advanced radiation therapies. By collaborating closely with medical professionals and facility managers, they empower healthcare providers to help patients reclaim their lives swiftly and efficiently.
Global Presence
Headquartered in Madison, Accuray has established a worldwide presence, ensuring that their cutting-edge solutions are accessible to diverse patient populations. This global footprint enhances their operations, enabling them to implement innovations that respond to distinct medical needs.
Investor and Media Contact Information
For more information, investors can reach out to Aman Patel, CFA at ICR-Westwicke, or contact the media through Beth Kaplan, Public Relations Director at Accuray. They both can provide further insights into recent company developments and upcoming initiatives.
Frequently Asked Questions
When will Accuray announce its Q1 financial results?
Accuray will announce its financial results for the first quarter of fiscal 2025 on November 6, 2024.
How can investors participate in the earnings call?
Investors can participate in the earnings call by dialing (833) 316-0563 for USA participants or (412) 317-5747 for international participants.
Is there a replay available for the conference call?
Yes, a replay of the conference call will be available for one week following the event.
Where can I find the live webcast?
The live webcast will be available on the Investor Relations section of Accuray's official website.
What is the primary focus of Accuray?
Accuray focuses on innovating radiation therapy technologies to improve patient care across various medical disciplines, including oncology and neuro-radiosurgery.